Table 1 Descriptive characteristics of participants
|  | Male (n = 260) | Female (n = 273) | Total (n = 533) | Male vs Female | |||
|---|---|---|---|---|---|---|---|
| Â | Median (IQR) | Min-Max | Median (IQR) | Min-Max | Median (IQR) | Min-Max | p-value |
Age (years) | 39 (18) | 20–65 | 39 (21) | 18–64 | 39 (20) | 18–65 | 0.971 |
Height (cms) | 172 (8) | 156–191 | 160 (9) | 143–191 | 167 (13) | 143–191 | 0.000 |
Weight (kg) | 74 (19) | 46–116 | 68 (16) | 38–109 | 70 (18) | 38–116 | 0.000 |
BMI (kg/m2) | 24.9 (5.6) | 16.3–34.9 | 26.1 (6.3) | 17.1–38.1 | 25.5 (5.9) | 16.3–38.1 | 0.051 |
BSA (m2) | 1.88 (0.24) | 1.44–2.36 | 1.72 (0.20) | 1.27–2.24 | 1.78 (0.22) | 1.27–2.36 | 0.000 |
Abd. Circ. (cm) | 91 (15) | 65–124 | 86 (16) | 64–115 | 89 (17) | 64–124 | 0.005 |
BP Systolic (mmHg) | 127 (18) | 84–179 | 128 (18) | 118 (20) | 124 (21) | 77–194 | 0.000 |
BP Diastolic (mmHg) | 81 (12) | 56–101 | 79 (14) | 57–112 | 80 (14) | 56–112 | 0.003 |
aFPG (mmol/L) | 4.9 (0.8) | 3.0–15.6 | 4.8 (0.7) | 3.3–19.5 | 4.9 (0.8) | 3.0–19.5 | 0.191 |
Creatinine (μmol/L) | 80 (20) | 50–126 | 61 (15) | 30–93 | 70 (21) | 30–126 | 0.000 |
4v–MDRD eGFR (mL/min/1.73m2) | 114 (34) | 61–184 | 118 (34) | 69–251 | 115 (33) | 61–251 | 0.126 |
4v–MDRDb eGFR (mL/min/1.73m2) | 94 (28) | 50–152 | 97 (28) | 57–207 | 95 (28) | 50–207 | 0.126 |
CKDEPI eGFR (mL/min/1.73m2) | 118 (25) | 60–151 | 124 (25) | 71–168 | 121 (25) | 60–168 | 0.090 |
CKDEPI eGFRb (mL/min/1.73m2) | 102 (21) | 52–130 | 107 (22) | 62–146 | 105 (22) | 52–146 | 0.061 |
CG eGFRc (mL/min/1.73m2) | 103 (26) | 55–163 | 163 (45) | 85–345 | 128 (61) | 55–345 | 0.000 |
FAS eGFR (mL/min/1.73m2) | 100 (23) | 51–163 | 104 (25) | 58–200 | 102 (25) | 51–200 | 0.309 |